SAGE
Price
$6.85
Change
+$0.07 (+1.03%)
Updated
Jun 6 closing price
Capitalization
428.95M
59 days until earnings call
VERV
Price
$6.20
Change
+$0.47 (+8.20%)
Updated
Jun 6 closing price
Capitalization
552.24M
61 days until earnings call
Interact to see
Advertisement

SAGE vs VERV

Header iconSAGE vs VERV Comparison
Open Charts SAGE vs VERVBanner chart's image
Sage Therapeutics
Price$6.85
Change+$0.07 (+1.03%)
Volume$772.67K
Capitalization428.95M
Verve Therapeutics
Price$6.20
Change+$0.47 (+8.20%)
Volume$4.68M
Capitalization552.24M
SAGE vs VERV Comparison Chart
Loading...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SAGE vs. VERV commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SAGE is a StrongBuy and VERV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (SAGE: $6.85 vs. VERV: $6.20)
Brand notoriety: SAGE and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SAGE: 79% vs. VERV: 112%
Market capitalization -- SAGE: $428.95M vs. VERV: $552.24M
SAGE [@Biotechnology] is valued at $428.95M. VERV’s [@Biotechnology] market capitalization is $552.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SAGE’s FA Score shows that 1 FA rating(s) are green whileVERV’s FA Score has 1 green FA rating(s).

  • SAGE’s FA Score: 1 green, 4 red.
  • VERV’s FA Score: 1 green, 4 red.
According to our system of comparison, VERV is a better buy in the long-term than SAGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SAGE’s TA Score shows that 6 TA indicator(s) are bullish while VERV’s TA Score has 5 bullish TA indicator(s).

  • SAGE’s TA Score: 6 bullish, 4 bearish.
  • VERV’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SAGE is a better buy in the short-term than VERV.

Price Growth

SAGE (@Biotechnology) experienced а +6.04% price change this week, while VERV (@Biotechnology) price change was +39.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

SAGE is expected to report earnings on Aug 05, 2025.

VERV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($552M) has a higher market cap than SAGE($429M). SAGE YTD gains are higher at: 26.151 vs. VERV (9.840). VERV has higher annual earnings (EBITDA): -221.91M vs. SAGE (-358.98M). VERV has more cash in the bank: 524M vs. SAGE (424M). SAGE has less debt than VERV: SAGE (11.9M) vs VERV (70M). SAGE has higher revenues than VERV: SAGE (47.4M) vs VERV (32.3M).
SAGEVERVSAGE / VERV
Capitalization429M552M78%
EBITDA-358.98M-221.91M162%
Gain YTD26.1519.840266%
P/E RatioN/AN/A-
Revenue47.4M32.3M147%
Total Cash424M524M81%
Total Debt11.9M70M17%
FUNDAMENTALS RATINGS
SAGE: Fundamental Ratings
SAGE
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SAGEVERV
RSI
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDGTX22.09N/A
N/A
Fidelity Advisor Dividend Growth M
TESRX25.03N/A
N/A
Franklin Mutual Shares R
AWSAX16.34N/A
N/A
Invesco Global Core Equity A
LSVMX10.71N/A
N/A
LSV US Managed Volatility Institutional
FIFQX22.88N/A
N/A
Fidelity Advisor Founders C